收费全文 | 980468篇 |
免费 | 66974篇 |
国内免费 | 2523篇 |
耳鼻咽喉 | 13733篇 |
儿科学 | 31170篇 |
妇产科学 | 28379篇 |
基础医学 | 137721篇 |
口腔科学 | 26983篇 |
临床医学 | 79867篇 |
内科学 | 201344篇 |
皮肤病学 | 21395篇 |
神经病学 | 77842篇 |
特种医学 | 38091篇 |
外国民族医学 | 338篇 |
外科学 | 152037篇 |
综合类 | 19440篇 |
一般理论 | 272篇 |
预防医学 | 74238篇 |
眼科学 | 22002篇 |
药学 | 70247篇 |
中国医学 | 2069篇 |
肿瘤学 | 52797篇 |
2019年 | 8034篇 |
2018年 | 11953篇 |
2017年 | 8867篇 |
2016年 | 9288篇 |
2015年 | 10582篇 |
2014年 | 14332篇 |
2013年 | 22391篇 |
2012年 | 31191篇 |
2011年 | 32906篇 |
2010年 | 19378篇 |
2009年 | 17808篇 |
2008年 | 30703篇 |
2007年 | 32591篇 |
2006年 | 32596篇 |
2005年 | 32163篇 |
2004年 | 30568篇 |
2003年 | 29396篇 |
2002年 | 28808篇 |
2001年 | 43629篇 |
2000年 | 44936篇 |
1999年 | 38168篇 |
1998年 | 10338篇 |
1997年 | 9355篇 |
1996年 | 9314篇 |
1995年 | 8624篇 |
1994年 | 8233篇 |
1993年 | 7707篇 |
1992年 | 29173篇 |
1991年 | 27851篇 |
1990年 | 27260篇 |
1989年 | 26115篇 |
1988年 | 24257篇 |
1987年 | 23875篇 |
1986年 | 22903篇 |
1985年 | 21789篇 |
1984年 | 16273篇 |
1983年 | 13851篇 |
1982年 | 8254篇 |
1979年 | 15088篇 |
1978年 | 10512篇 |
1977年 | 8867篇 |
1976年 | 8418篇 |
1975年 | 9243篇 |
1974年 | 11147篇 |
1973年 | 10621篇 |
1972年 | 10020篇 |
1971年 | 9242篇 |
1970年 | 8963篇 |
1969年 | 8382篇 |
1968年 | 8031篇 |
Introduction
The fast track / ultra-fast-track protocols are techniques used to optimise the patient care process and a quick recovery after cardiac surgery. They are one of the mainstays of efficient practice. With their use, the length of hospital and intensive care unit (ICU) stays are reduced, with a direct impact on costs and the quality of the health service.Objective
To compare the length of stay in the ICU, length of hospital stay, and post-operative mortality in ultra-fast-track extubated (uFTE) patients and those with conventional extubation (CE) after cardiac surgery.Methods
Longitudinal, analytical, retrospective study was conducted, with the period between the time of surgery and discharge being included as the study period.Results
A total of 396 patients older than 18 years who required cardiac surgery were included, of whom 207 patients had (uFTE) and 189 had CE. Although the groups were not comparable due to the statistical differences found, when performing the multivariate adjustment, uFTE maintained its statistical independence and was associated with lower cardiovascular morbidity, such as myocardial ischaemia (95% CI: 0.37-0.86; P = .01) and lower post-surgical vasopressor requirement (95% CI: 0.18-0.49; P < .01). No significant differences were found in the length of hospital stay, ICU stay, or post-operative mortality in the ICU.Conclusion
Implementing the uFTE strategy, decreases cardiovascular morbidity and vasopressor requirement. The change to uFTE should be accompanied by changes in models and practices in patient recovery to standardised protocols. This study shows that uFTE did not reduce the length of ICU stay, hospital stay, or mortality. 相似文献Methods: A retrospective analysis was performed to identify patients with isolated PCL injuries that underwent reconstruction between 2001 and 2014. Patients with multi-ligamentous injury or another concomitant knee pathology were excluded. Medical records were reviewed for demographic, clinical and operative data. Patients were contacted for administration of a telephone-based questionnaire which included the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation form, Lysholm-Tegner scales, Marx activity scale (MAS), return to sport status, and patient satisfaction instruments.
Results: A total of 15 isolated PCL reconstructions in 14 patients with a mean age of 27.5 years (range 17–43) met the study inclusion criteria; mean follow up was 6.3 years (range 1.4–15.2). Pre-operatively, the primary complaint was knee instability in all patients; on physical examination, lack of a firm end point during posterior drawer testing was found in 93% (14/15) of the knees. In total, 12 of 15 knees underwent transtibial, single-bundle PCLR and three of 15 underwent tibial inlay, double bundle PCLR. Graft types included: quadriceps autograft (7/15), Achilles allograft (6/15), and hamstring autograft (2/15). There were no graft failures in our patient cohort. At most recent follow up the mean scores respectively on the IKDC form, Lysholm-Tegner scales and MAS were (standard deviation): 77.3 (16.5), 83.1 (17.9), 6.13 (2.6), and 7.1 (6.0). All fourteen patients were athletes prior to their injury and 79% (11/14) returned to sport and overall patient satisfaction was 9.2/10.
Conclusions: Isolated PCLR provides good outcomes at mean medium-term follow up with restoration of function, high rate of return to sport and overall patient satisfaction. 相似文献
Background
Etomidate is frequently selected over propofol for induction of anaesthesia because of a putatively favourable haemodynamic profile, but data confirming this perception are limited.Methods
Patients undergoing cardiac surgery were randomised to induction of anaesthesia with propofol or etomidate. Phase I (n=75) was conducted as open-label, whereas Phase II (n=75) was double blind. Mean arterial blood pressure (MAP) and boluses of vasopressor administered after induction were recorded. The primary endpoint was the area under the curve below baseline MAP (MAP-time integral) during the 10 min after induction. Secondary endpoints were the use of vasopressors over the same period, and the effect of blinding on the aforementioned endpoints. Groups were compared using regression models with phase and anaesthetist as factors.Results
The mean difference between etomidate and propofol in the MAP-time integral below baseline was 2244 mm Hg s (95% confidence interval, 581–3906; P=0.009), representing a 34% greater reduction with propofol. Overall, vasopressors were used in 10/75 patients in the etomidate group vs 21/75 in the propofol group (P=0.38), and in 20/74 patients during the blinded phase vs 11/76 during the open-label phase (P=0.31). The interaction between randomisation and phase (open-labelled or blinded) was not significant for either primary (P=0.73) or secondary endpoints (P=0.90).Conclusions
Propofol caused a 34% greater reduction in MAP-time integral from baseline after induction of anaesthesia than etomidate, despite more frequent use of vasopressors with propofol, confirming the superior haemodynamic profile of etomidate in this context. The proportion of patients receiving vasopressors increased slightly, albeit not significantly, in both groups in the blinded phase.Clinical trial registration
Australian and New Zealand Clinical Trials Registry, ACTRN12614000717651. 相似文献Areas covered: We discuss the potential mechanism supporting the contribution of visfatin to RA and the association between RA and obesity. We discuss the repurposing of cancer-tested drugs to inhibit visfatin in the context of RA. Additionally, we address the possibility of combining these drugs with current RA therapy. Finally, we explore the future of visfatin as an RA biomarker or therapeutic target.
Expert opinion: Inhibition of visfatin has become an interesting therapeutic approach for RA pathology. Such a feat has already been attained in oncology using small molecule inhibitors, which suggest that a similar course of action would be worth pursuing in the RA context. Visfatin will become an important biomarker and therapeutic target for RA. 相似文献